There are growing concerns that Merck and potentially other pharmaceutical giants are working behind the scenes to shut down all generic production of ivermectin, particularly in India where more than 50 different companies currently manufacture it for the global market. Dr. Kazuhiro Nagao, chair
This post was created with our nice and easy submission form. Create your post!
Comments
Loading…